Gene · 90427
Papers1,838
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,838
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptomic suppression of immune and ECM stability in skeletal muscle of patients with chronic kidney disease. | PLoS One | 2026 | 41734178 | PubTator, text mining | PubMed |
| SELE is associated with reduced breast cancer susceptibility: Evidence from Mendelian randomization and single-cell transcriptome. | Transl Oncol | 2026 | 41722201 | PubTator, text mining | PubMed |
| TG221: An Experimental Model for Liver Cancer Prevention and Treatment Approaches. | BioTech (Basel) | 2026 | 41718347 | PubTator, text mining | PubMed |
| Identification and Verification of Anoikis-related Genes in Epilepsy Through Bioinformatics Analysis. | Brain Behav | 2026 | 41699870 | PubTator, text mining | PubMed |
| DNTTIP1 drives leukaemogenesis through MiDAC-mediated epigenetic silencing of BMF. | Clin Transl Med | 2026 | 41603084 | PubTator, text mining | PubMed |
| A microphysiological model of human MASLD reveals paradoxical response to resmetirom. | Commun Biol | 2026 | 41535580 | PubTator, text mining | PubMed |
| Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms. | J Immunother Cancer | 2026 | 41529908 | PubTator, text mining | PubMed |
| EZH2 Inhibitors Sensitize Breast Cancer to HER2 Kinase Inhibitors through Cooperative Effects on YAP and Proapoptotic Regulators. | Cancer Res | 2026 | 41490884 | PubTator, text mining | PubMed |
| Bcl-2 modifying factor (Bmf): "a mysterious stranger" in the Bcl-2 family proteins. | Cell Death Differ | 2026 | 40849581 | PubTator, text mining | PubMed |
| Endometriosis: From Genes to Global Burden. | Int J Mol Sci | 2025 | 41516028 | PubTator, text mining | PubMed |
| MicroRNA-221: A Context-Dependent Mediator in Human Diseases-Highlights from Molecular Mechanisms to Clinical Translation. | Cells | 2025 | 41369385 | PubTator, text mining | PubMed |
| Identification of oxidative stress-responsive genes in recurrent miscarriage and their role in disease pathogenesis. | PLoS One | 2025 | 41329780 | PubTator, text mining | PubMed |
| Enhanced anti-tumor efficacy of tumor-infiltrating lymphocytes by GITR agonist in ovarian cancer. | Front Immunol | 2025 | 41280919 | PubTator, text mining | PubMed |
| METAP2 inhibits K48-linked ubiquitination of YTHDF2 to promote ovarian cancer progression. | Oncogene | 2025 | 41102384 | PubTator, text mining | PubMed |
| Cul5Wsb2 uses BCL2 proteins as co-receptors to target Bim for degradation. | bioRxiv | 2025 | 40832228 | PubTator, text mining | PubMed |
| NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts. | Signal Transduct Target Ther | 2025 | 40820091 | PubTator, text mining | PubMed |
| A Promising Breakthrough for Triple-Negative Breast Cancer by Targeting the AKT and EZH2. | MedComm (2020) | 2025 | 40766180 | PubTator, text mining | PubMed |
| SNAI2 cooperates with MEK1/2 and HDACs to suppress BIM- and BMF-dependent apoptosis in TERT promoter mutant cancers. | PLoS One | 2025 | 40560846 | PubTator, text mining | PubMed |
| Narciclasine enhances cisplatin-induced apoptotic cell death by inducing unfolded protein response-mediated regulation of NOXA and MCL1. | Cell Mol Biol Lett | 2025 | 40369444 | PubTator, text mining | PubMed |
| Leveraging Diverse Cell-Death Patterns to Decipher the Interactive Relation of Unfavorable Outcome and Tumor Microenvironment in Breast Cancer. | Bioengineering (Basel) | 2025 | 40281780 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90427/papers?page=2